Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cellectis S.A. (CLLS)

« Back to company index

CLLS Chatter Timeline

Stock Ticker for CLLS

Most Active Tweeters for CLLS

UserTweets
@OlympiaReport 3
@whatsonthorold2 3
@reurope_stock 3
@bibeypost_stock 3
@MareaInformativ 2

Recent Tweets for CLLS

bibeypost_stock @bibeypost_stock
How Many Cellectis S.A. $CLLS's Analysts Are Bearish? - https://t.co/JMmFqrnUNa
July 15th 2018, 10:07am
reurope_stock @reurope_stock
Analysts are on the Bearish side about Cellectis S.A. $CLLS this week. https://t.co/J1v3QPYUjH
July 15th 2018, 10:07am
mmahotstuff1 @mmahotstuff1
Analysts are on the Bearish side about Cellectis S.A. $CLLS this week. - https://t.co/463uVN5bSw
July 15th 2018, 10:07am
whatsonthorold2 @whatsonthorold2
Can analysts adopt a bullish outlook for Cellectis S.A. $CLLS? - https://t.co/FvWWaIfckT
July 15th 2018, 10:07am
ThisLincolnian @ThisLincolnian
Cellectis $CLLS Downgraded by BidaskClub to “Strong Sell” https://t.co/F4OnIVbKUR
July 15th 2018, 9:07am
ConsumerFeed @ConsumerFeed
Cellectis $CLLS Downgraded by Zacks Investment Research https://t.co/DU6oGCYTVQ
July 15th 2018, 4:07am
OlympiaReport @OlympiaReport
Cellectis $CLLS Downgraded by Zacks Investment Research https://t.co/Fq77m9FVY6
July 14th 2018, 8:07pm
dispatchtribune @dispatchtribune
Cellectis $CLLS Downgraded by BidaskClub to Strong Sell https://t.co/uTvFbYg8E6
July 14th 2018, 5:07pm
OlympiaReport @OlympiaReport
Cellectis $CLLS Downgraded by BidaskClub to Strong Sell https://t.co/aZBmdHaRGO
July 14th 2018, 5:07pm
apppro1 @apppro1
RT @StockReversals: $CLLS remains woefully undervalued. Add up cash, partnerships, and ownership of $CLXT and they are nearly giving away…
July 13th 2018, 8:07am
ConsumerFeed @ConsumerFeed
Analysts Expect Cellectis SA $CLLS Will Announce Earnings of -$0.34 Per Share https://t.co/m1wIBetDU0
July 12th 2018, 12:07pm
StockReversals @StockReversals
$CLLS remains woefully undervalued. Add up cash, partnerships, and ownership of $CLXT and they are nearly giving away the CAR-T pipe
July 12th 2018, 9:07am
MareaInformativ @MareaInformativ
Analysts Expect Cellectis SA $CLLS Will Announce Earnings of -$0.34 Per Share https://t.co/lSGhR4l2DR
July 12th 2018, 9:07am
WatchlistN @WatchlistN
Cellectis $CLLS Rating Lowered to Hold at Zacks Investment Research https://t.co/dYRrnFlRM6
July 12th 2018, 3:07am
TickerReport @TickerReport
Cellectis $CLLS Cut to Hold at Zacks Investment Research https://t.co/sVxoxO7CUU
July 12th 2018, 3:07am
MareaInformativ @MareaInformativ
Cellectis SA $CLLS Expected to Announce Quarterly Sales of $9.43 Million https://t.co/OxMx3MV8EW
July 11th 2018, 6:07am
bibeypost_stock @bibeypost_stock
$-0.66 EPS Expected for Cellectis S.A. $CLLS - https://t.co/TF1EAbsurQ
July 11th 2018, 6:07am
AviseAnalytics @AviseAnalytics
RT @reurope_stock: EPS for Cellectis S.A. $CLLS Expected At $-0.66 https://t.co/zOR70jM6sX
July 11th 2018, 6:07am
reurope_stock @reurope_stock
EPS for Cellectis S.A. $CLLS Expected At $-0.66 https://t.co/zOR70jM6sX
July 11th 2018, 6:07am
The_CasualSmart @The_CasualSmart
Cellectis S.A. $CLLS Analysts See $-0.66 EPS https://t.co/8tQeuWZt1p
July 11th 2018, 6:07am
mmahotstuff1 @mmahotstuff1
$-0.66 EPS Expected for Cellectis S.A. $CLLS - https://t.co/rnK5R51LYS
July 11th 2018, 6:07am
whatsonthorold2 @whatsonthorold2
Cellectis S.A. $CLLS EPS Estimated At $-0.66 - https://t.co/t1c1ukCa2O
July 11th 2018, 6:07am
The_CasualSmart @The_CasualSmart
$-0.66 EPS Expected for Cellectis S.A. $CLLS https://t.co/9GRRc4wdzp
July 11th 2018, 6:07am
AmericanBanking @AmericanBanking
Cellectis SA $CLLS Expected to Announce Quarterly Sales of $9.43 Million https://t.co/CStfV1lGWx #stocks
July 11th 2018, 3:07am
ZolmaxNews @ZolmaxNews
Cellectis $CLLS Downgraded by Zacks Investment Research to Hold https://t.co/A1jK8pvTey
July 10th 2018, 8:07pm
dailypoliticaln @dailypoliticaln
Cellectis $CLLS Downgraded by Zacks Investment Research to Hold https://t.co/q42QoETLMS
July 10th 2018, 8:07pm
AmericanBanking @AmericanBanking
Cellectis SA $CLLS Expected to Announce Earnings of -$0.34 Per Share https://t.co/NeGVK8uVZI #stocks
July 9th 2018, 8:07am
mchilberg @mchilberg
$ATRA is ramping in EU. Going after $CLLS in CAR-T? VP-France, VP-Germany, Head of comm ops and Mktg-Switz for a… https://t.co/6lGNmdcorO
July 6th 2018, 11:07am
savepiginvest @savepiginvest
RT @BiotechRadar: Precision Biosciences' CD19 allogeneic CAR-T granted Orphan Drug Status by the FDA $ALCLS $CLLS https://t.co/xqf2q3MOPk
July 6th 2018, 6:07am
BiotechRadar @BiotechRadar
Precision Biosciences' CD19 allogeneic CAR-T granted Orphan Drug Status by the FDA $ALCLS $CLLS https://t.co/xqf2q3MOPk
July 6th 2018, 6:07am
bibeypost_stock @bibeypost_stock
EPS for Cellectis S.A. $CLLS Expected At $-0.66 - https://t.co/c72cLw2Nln
July 4th 2018, 10:07pm
reurope_stock @reurope_stock
$-0.66 EPS Expected for Cellectis S.A. $CLLS https://t.co/wyr4uDGXpY
July 4th 2018, 10:07pm
whatsonthorold2 @whatsonthorold2
Cellectis S.A. $CLLS EPS Estimated At $-0.66 - https://t.co/qobARlXoEx
July 4th 2018, 10:07pm
Haemophage @Haemophage
RT @BiotechRadar: The Quest for Off-the-Shelf CAR T Cells $ALCLS $CLLS #Poseida Sadelain/Rosenberg/Maus/Ostertag/Choulika https://t.co/Kac…
July 4th 2018, 8:07pm
OlympiaReport @OlympiaReport
Analysts Set Cellectis SA $CLLS Target Price at $42.67 https://t.co/4P0Ga4FM04
July 4th 2018, 6:07pm
dispatchtribune @dispatchtribune
Cellectis SA $CLLS Given Consensus Rating of “Hold” by Brokerages https://t.co/l69RuA8uD4
July 4th 2018, 6:07pm
BiotechRadar @BiotechRadar
The Quest for Off-the-Shelf CAR T Cells $ALCLS $CLLS #Poseida Sadelain/Rosenberg/Maus/Ostertag/Choulika… https://t.co/WwKvo1d5mJ
July 4th 2018, 5:07am
dakotafinancial @dakotafinancial
Analysts Set Cellectis SA $CLLS Target Price at $42.67 https://t.co/8hQkilEdaS
July 2nd 2018, 3:07pm
registrarjourn @registrarjourn
Cellectis SA $CLLS Receives $42.67 Consensus PT from Brokerages https://t.co/TrxO5oLpdx
July 2nd 2018, 3:07pm
portefeuillefun @portefeuillefun
RT @mchilberg: BoA comment on #Allogeneic CAR-T #CellTherapy $CLLS $NVS https://t.co/cBsT1LCeHC
July 1st 2018, 12:07am
mchilberg @mchilberg
BoA comment on #Allogeneic CAR-T #CellTherapy $CLLS $NVS https://t.co/cBsT1LCeHC
June 30th 2018, 3:06pm
MareaInformativ @MareaInformativ
Cellectis SA $CLLS Given Consensus Recommendation of “Hold” by Analysts https://t.co/P2WmBrISfs
June 29th 2018, 6:06am
WeekHerald @WeekHerald
Cellectis SA $CLLS Given Consensus Recommendation of “Hold” by Brokerages https://t.co/YdADCl3J5q
June 29th 2018, 6:06am
AvisKarim @AvisKarim
$CLLS $CLXT https://t.co/jl34gCe9WC https://t.co/Wqaaxn5CDN
June 29th 2018, 2:06am
MichelDoepke @MichelDoepke
Gene Editing Technologies Market Latest Innovations, Drivers and Industry Key Events 2025 #GeneEditing $SGMO $CLLS… https://t.co/mMNYmiQTCZ
June 28th 2018, 1:06pm
dhovekamp42 @dhovekamp42
RT @BehaviorFin: $CLLS $ALCLS Shareholder meeting : UCART 19: about 15 patients planned in trials UCART123: 15 patients undergoing trial. D…
June 28th 2018, 11:06am
dhovekamp42 @dhovekamp42
RT @BehaviorFin: $CLLS $ALCLS Shareholder meeting : On solid tumor: CD25+interleukine12; to be announced Cash OK until 2022 Happy w #Alloge…
June 28th 2018, 11:06am
BehaviorFin @BehaviorFin
$CLLS $ALCLS Shareholder meeting : On solid tumor: CD25+interleukine12; to be announced Cash OK until 2022 Happy w… https://t.co/kSsMCONtYa
June 28th 2018, 6:06am
BehaviorFin @BehaviorFin
$CLLS $ALCLS Shareholder meeting : UCART 19: about 15 patients planned in trials UCART123: 15 patients undergoing t… https://t.co/spGL9dLJL0
June 28th 2018, 6:06am
BehaviorFin @BehaviorFin
$CLLS $ALCLS Shareholder meeting https://t.co/ggyb0skhwJ https://t.co/DexfdCR4Jc
June 28th 2018, 3:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.